Skip to content
CancerIndex

Ranking · Unmet Need

Trial Gap Index

Burden percentile minus active-trial percentile within the same scope. Positive values flag cancers with high mortality burden but comparatively few active trials. A quantitative signal, not an accusation (CLAUDE.md §324). Caveat (Phase 1): trial counts aggregate a cancer and its NCIt descendants only; registrations phrased at a broader level (e.g. "colorectal cancer" for colon and rectal cancer) are attributed to the broader entity, which can overstate the gap of narrower top-level sites.

Computedci-trial-gap-v1unit: percentile pointshigher = worseAll metrics

Top 15 by Trial Gap IndexMalignant Colon Neoplasm+56.7Malignant Bladder Neoplasm+23.3Cutaneous Melanoma+20Malignant Laryngeal Neoplasm+16.7Malignant Vulvar Neoplasm+13.4Malignant Pancreatic Neoplasm+10Malignant Vaginal Neoplasm+10Malignant Esophageal Neoplasm+3.4Malignant Salivary Gland Neop…+3.3Malignant Kidney Neoplasm+3.3Malignant Mesothelioma+3.3Malignant Liver Neoplasm0Malignant Lung Neoplasm0Malignant Prostate Neoplasm0Malignant Rectal Neoplasm0
RankΔCancerTrial Gap Index (percentile points)PercentileConfidenceSourcesWhy #n?
1=Malignant Colon Neoplasm+56.7100Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
41865
formula
percentile(mortality_count) − percentile(active_trials)
activity
225
burdenPercentile
96.7
activityPercentile
40

ranking row 2600374

2=Malignant Bladder Neoplasm+23.396.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
15775
formula
percentile(mortality_count) − percentile(active_trials)
activity
346
burdenPercentile
70
activityPercentile
46.7

ranking row 2600375

3=Cutaneous Melanoma+2093.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
9324
formula
percentile(mortality_count) − percentile(active_trials)
activity
78
burdenPercentile
46.7
activityPercentile
26.7

ranking row 2600376

4=Malignant Laryngeal Neoplasm+16.790Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
3757
formula
percentile(mortality_count) − percentile(active_trials)
activity
66
burdenPercentile
36.7
activityPercentile
20

ranking row 2600377

5=Malignant Vulvar Neoplasm+13.486.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
1085
formula
percentile(mortality_count) − percentile(active_trials)
activity
54
burdenPercentile
26.7
activityPercentile
13.3

ranking row 2600378

6=Malignant Pancreatic Neoplasm+1083.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
40418
formula
percentile(mortality_count) − percentile(active_trials)
activity
904
burdenPercentile
90
activityPercentile
80

ranking row 2600379

6=Malignant Vaginal Neoplasm+1083.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
430
formula
percentile(mortality_count) − percentile(active_trials)
activity
31
burdenPercentile
10
activityPercentile
0

ranking row 2600380

8=Malignant Esophageal Neoplasm+3.476.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
14935
formula
percentile(mortality_count) − percentile(active_trials)
activity
518
burdenPercentile
66.7
activityPercentile
63.3

ranking row 2600381

9=Malignant Salivary Gland Neoplasm+3.373.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
953
formula
percentile(mortality_count) − percentile(active_trials)
activity
63
burdenPercentile
20
activityPercentile
16.7

ranking row 2600382

10=Malignant Kidney Neoplasm+3.370Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
13917
formula
percentile(mortality_count) − percentile(active_trials)
activity
453
burdenPercentile
60
activityPercentile
56.7

ranking row 2600384

10=Malignant Mesothelioma+3.370Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
2599
formula
percentile(mortality_count) − percentile(active_trials)
activity
96
burdenPercentile
33.3
activityPercentile
30

ranking row 2600383

12=Malignant Liver Neoplasm063.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
24698
formula
percentile(mortality_count) − percentile(active_trials)
activity
906
burdenPercentile
83.3
activityPercentile
83.3

ranking row 2600386

12=Malignant Lung Neoplasm063.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
155526
formula
percentile(mortality_count) − percentile(active_trials)
activity
2644
burdenPercentile
100
activityPercentile
100

ranking row 2600385

12=Malignant Prostate Neoplasm063.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
28343
formula
percentile(mortality_count) − percentile(active_trials)
activity
1375
burdenPercentile
86.7
activityPercentile
86.7

ranking row 2600387

12=Malignant Rectal Neoplasm063.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
9786
formula
percentile(mortality_count) − percentile(active_trials)
activity
386
burdenPercentile
50
activityPercentile
50

ranking row 2600389

12=Malignant Testicular Neoplasm063.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
411
formula
percentile(mortality_count) − percentile(active_trials)
activity
43
burdenPercentile
6.7
activityPercentile
6.7

ranking row 2600388

17=Malignant Thyroid Gland Neoplasm-3.346.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
1832
formula
percentile(mortality_count) − percentile(active_trials)
activity
176
burdenPercentile
30
activityPercentile
33.3

ranking row 2600390

18=Malignant Breast Neoplasm-3.443.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
41676
formula
percentile(mortality_count) − percentile(active_trials)
activity
2627
burdenPercentile
93.3
activityPercentile
96.7

ranking row 2600391

18=Malignant Central Nervous System Neoplasm-3.443.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
15997
formula
percentile(mortality_count) − percentile(active_trials)
activity
823
burdenPercentile
73.3
activityPercentile
76.7

ranking row 2600392

20=Malignant Anal Neoplasm-6.636.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
922
formula
percentile(mortality_count) − percentile(active_trials)
activity
68
burdenPercentile
16.7
activityPercentile
23.3

ranking row 2600393

21=Malignant Hypopharyngeal Neoplasm-6.733.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
338
formula
percentile(mortality_count) − percentile(active_trials)
activity
53
burdenPercentile
3.3
activityPercentile
10

ranking row 2600394

21=Malignant Penile Neoplasm-6.733.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
309
formula
percentile(mortality_count) − percentile(active_trials)
activity
43
burdenPercentile
0
activityPercentile
6.7

ranking row 2600395

23=Malignant Ovarian Neoplasm-6.726.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
14195
formula
percentile(mortality_count) − percentile(active_trials)
activity
684
burdenPercentile
63.3
activityPercentile
70

ranking row 2600396

24=Leukemia-1023.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
23564
formula
percentile(mortality_count) − percentile(active_trials)
activity
1769
burdenPercentile
80
activityPercentile
90

ranking row 2600397

24=Malignant Uterine Corpus Neoplasm-1023.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
4160
formula
percentile(mortality_count) − percentile(active_trials)
activity
411
burdenPercentile
43.3
activityPercentile
53.3

ranking row 2600398

26=Hodgkin Lymphoma-13.416.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
1077
formula
percentile(mortality_count) − percentile(active_trials)
activity
179
burdenPercentile
23.3
activityPercentile
36.7

ranking row 2600399

27=Malignant Gastric Neoplasm-13.413.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
11311
formula
percentile(mortality_count) − percentile(active_trials)
activity
652
burdenPercentile
53.3
activityPercentile
66.7

ranking row 2600400

28=Multiple Myeloma-16.610Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
12112
formula
percentile(mortality_count) − percentile(active_trials)
activity
814
burdenPercentile
56.7
activityPercentile
73.3

ranking row 2600401

28=Non-Hodgkin Lymphoma-16.610Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
20387
formula
percentile(mortality_count) − percentile(active_trials)
activity
2168
burdenPercentile
76.7
activityPercentile
93.3

ranking row 2600402

30=Malignant Cervical Neoplasm-203.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
4115
formula
percentile(mortality_count) − percentile(active_trials)
activity
505
burdenPercentile
40
activityPercentile
60

ranking row 2600403

31=Malignant Nasopharyngeal Neoplasm-300Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
672
formula
percentile(mortality_count) − percentile(active_trials)
activity
261
burdenPercentile
13.3
activityPercentile
43.3

ranking row 2600404

Data updated 16 hours agoSource updated unknown31 eligible entities · inputs hash f06d08edd50dc77d23b6f20b